| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/12/2004 | WO2004012749A1 An analgesic agent for newborn or fetal subjects |
| 02/12/2004 | WO2004012748A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 02/12/2004 | WO2004012747A1 Air spray for water intake adjustment |
| 02/12/2004 | WO2004012742A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 02/12/2004 | WO2004012741A1 Sustained release formulations comprising lamotrigine |
| 02/12/2004 | WO2004012734A1 Patch for transdermal administration |
| 02/12/2004 | WO2004012730A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/12/2004 | WO2004012722A2 Bicifadine formulation |
| 02/12/2004 | WO2004012721A2 Hot melt tts for administering rotigotine |
| 02/12/2004 | WO2004012720A1 Process for making orally consumable dosage forms |
| 02/12/2004 | WO2004012719A1 Improved transdermal delivery system |
| 02/12/2004 | WO2004012718A1 New film coating |
| 02/12/2004 | WO2004012717A1 Delayed release anti-neoplastic product, use and formulation thereof |
| 02/12/2004 | WO2004012716A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/12/2004 | WO2004012715A1 Sustained release formulations of metformin |
| 02/12/2004 | WO2004012714A1 Oral dosage forms of water insoluble drugs and methods of making the same |
| 02/12/2004 | WO2004012713A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | WO2004012712A1 Methods and compositions for treating benign gynecological disorders, contraception, and hormone replacement |
| 02/12/2004 | WO2004012711A1 Crystalline drug particles prepared using a controlled precipitation process |
| 02/12/2004 | WO2004012710A1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | WO2004012709A1 Cochleates without metal cations as the bridging agents |
| 02/12/2004 | WO2004012708A1 Intravenous pharmaceutical form of administration |
| 02/12/2004 | WO2004012707A1 Ascorbic acid salt suspensions and use thereof as antioxidants |
| 02/12/2004 | WO2004012705A1 A pharmaceutical formulation and its use in the treatment of inner ear diseases |
| 02/12/2004 | WO2004012704A1 Antibiotic product, use and formulation thereof |
| 02/12/2004 | WO2004012703A1 Injectable depot compositions and uses thereof |
| 02/12/2004 | WO2004012702A1 New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 02/12/2004 | WO2004012701A2 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. |
| 02/12/2004 | WO2004012700A2 Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release |
| 02/12/2004 | WO2004012699A2 Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
| 02/12/2004 | WO2004012690A1 A multi component moisture triggered contolled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst |
| 02/12/2004 | WO2004012672A2 Cell transport compositions and uses thereof |
| 02/12/2004 | WO2004012665A2 Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies |
| 02/12/2004 | WO2004012664A2 Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity |
| 02/12/2004 | WO2004012662A2 Improved treatment of cancer with glutamine |
| 02/12/2004 | WO2004012655A2 Anti-microbial compositions and methods of using same |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2004012509A1 Delayed release anti-fungal product, use and formulation thereof |
| 02/12/2004 | WO2003103596A3 Stabilized nanoparticle formulations of camptotheca derivatives |
| 02/12/2004 | WO2003097025A3 A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom |
| 02/12/2004 | WO2003094883A3 Process for the treatment of particles for use in pharmaceutical formulations |
| 02/12/2004 | WO2003086343A3 Fast disintegrating oral dosage forms |
| 02/12/2004 | WO2003086305A8 Biodegradable peg-based polymer formulations in ocular applications |
| 02/12/2004 | WO2003086041A3 Binding agents and their use in targeting tumor cells |
| 02/12/2004 | WO2003084507A3 Atomizable liposomes and their use for the pulmonary administration of active substances |
| 02/12/2004 | WO2003082220A3 Method for producing emulsions |
| 02/12/2004 | WO2003079885A3 Inhalable sustained therapeutic formulations |
| 02/12/2004 | WO2003077882A3 Preparation of sterile stabilized nanodispersions |
| 02/12/2004 | WO2003077825A3 Site specific delivery of co-administered drugs via inhalation |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003057141A3 Methods for improving the aesthetic appearance of skin |
| 02/12/2004 | WO2003057136A3 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 02/12/2004 | WO2003055584A3 Granules obtained by drying an emulsion comprising a polymer and a monosaccharide or a monosaccharide derivative |
| 02/12/2004 | WO2003053325A8 Microencapsulation of drugs by solvent exchange |
| 02/12/2004 | WO2003039485A3 Stable liquid pharmaceutical formulation of igg antibodies |
| 02/12/2004 | WO2003039331A3 Method for improving stability of a bone-connecting implant |
| 02/12/2004 | WO2003033526A3 Synthesis of cyclosporin analogs |
| 02/12/2004 | WO2003026733A9 Microneedle with membrane |
| 02/12/2004 | WO2003020336A3 Stabilizing catheter for protein drug delivery |
| 02/12/2004 | WO2002100338A3 Compound and composition for delivering active agents |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030323 Implantable medical pump with multi-layer back-up memory |
| 02/12/2004 | US20040030252 Methods for ultrasonic imaging and treating diseased tissues |
| 02/12/2004 | US20040030033 New film coating |
| 02/12/2004 | US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance |
| 02/12/2004 | US20040029977 Fine-grained emulsions |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029968 Reducing blood glucose concentration; antidiabetic agents; hydrophilic drug with protective coating |
| 02/12/2004 | US20040029966 Sustained release drug; drug overcoated with cellulose ether |
| 02/12/2004 | US20040029964 Calcium formate for use as a dietary supplement |
| 02/12/2004 | US20040029962 HMG-COA reductase inhibitor extended release formulation |
| 02/12/2004 | US20040029959 Isosorbide mononitrate compositions and methods of their use |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029934 Pharmaceutical emulsion preparation |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029924 Administering by mouth; enteric cellulose coated pellets; gastrointestinal disorders |
| 02/12/2004 | US20040029914 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/12/2004 | US20040029907 Drug for respiratory system disorders |
| 02/12/2004 | US20040029892 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 02/12/2004 | US20040029890 PH sensitivity; controlling blood concentration; cardiovascular disorders |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029856 Photodynamic therapy for the treatment of hair loss |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029843 Rapidly disintegrating formulations for treating or preventing mucositis |
| 02/12/2004 | US20040029830 Water-soluble indole-3-propionic acid |
| 02/12/2004 | US20040029821 Pharmaceutical composition containing an indolopyrrolocarbazole derivative |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029788 Methods and compositions for the treatment of diseases of the eye |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029783 Prevention, therapy of respiratory system disorders; administering to humans, animals |
| 02/12/2004 | US20040029777 Pharmaceutical preparation for taste masking |
| 02/12/2004 | US20040029776 Hydroxyethyl starch - containing polypeptide compositions |
| 02/12/2004 | US20040029774 Administering gel of chondroitin, glucosamine, gelatin, collage and dimethyl sulfone mixture; bioavailability |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |